Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Following media attention, $20K hospital bill lowered to $200

Media spotlighting of extraordinarily high hospital bills can pay off for patients on the hook for thousands of dollars after a hospital visit. Such is the case for one San Francisco resident who was stuck with a bill for more than $20,000—after her insurance paid its part—following a bicycle accident.

Trump meets with patients, doctors to discuss surprise medical bills

In an effort to curb “unexpected and outrageous bills,” President Trump invited patients and others to the White House to discuss their experiences with such pricing, Kaiser Health News reported. The discussion is part of Trump’s overall goal to impact drug prices and transparency in healthcare.

Thumbnail

Walgreens settles fraud cases for $269M

Walgreens Boots Alliance has settled two fraud cases with the Department of Justice, shelling out $269.2 million. In both cases, which arose from whistleblowers, Walgreens admitted and accepted responsibility for conduct alleged by the government in its complaint under the False Claims Act.

Thumbnail

Government shutdown poses risks to ACA, healthcare services

The U.S. government shutdown, which is now the longest-running in history, could potentially harm consumers and undermine the stability of the Affordable Care Act healthcare insurance market, The Wall Street Journal reported.

Thumbnail

Support for Medicare for all remains above 50%

As progressive Democrats increasingly push for universal healthcare, known as Medicare for all, support for such a plan is mixed when it comes to paying for it, according to a recent poll from the Kaiser Family Foundation.

Thumbnail

Pharma industry spending on lobbying exploded in 2018

The trade group for the U.S.'s top drugmakers spent a record amount—$27.5 million—on lobbying efforts in 2018, according to Bloomberg.

Thumbnail

More groups ask CMS to push back ACO deadline

More industry groups are pushing back against an upcoming deadline for accountable care organizations (ACOs) to apply to the updated Medicare Shared Savings Program.

Thumbnail

Medicare reimbursements don’t cover the cost of care

Medicare payments in 2019 aren’t likely to cover the cost of delivering care for two-thirds of medical practices, according to a survey from the Medical Group Management Association (MGMA).

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.